Replies to post #117 on Seagen Inc (SGEN)

[surf1944]

Seattle Genetics reiterated as a Sell at Canaccord
theflyonthewall

On Monday August 22, 2011, 7:09 am EDT

Canaccord said Adcetris' label supports a limited hemeonc market opportunity. The firm reiterates its Sell rating on Seattle Genetics with a $10 price target.